To elucidate whether or not the inhibition effect of GKB on NLRP3-related inflammasome activation (which leads to pro- IL-1β and pro-IL-18 being cleaved to creat mature bioactive forms) depends on autophagy modulation, we treated lung cancer cells with an autophagy inhibitor. The gene discussed is NLRP3; the disease is lung carcinoma.